Welcome to the international HTA database

Showing [16861 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Golimumab (Simponi) for ulcerative colitis - second line
2011	HAYES, Inc.	Capsule endoscopy for the diagnosis of small bowel Crohn's disease
2011	National Institute for Health and Care Excellence (NICE)	Off-pump coronary artery bypass grafting. NICE interventional procedures guidance 377
2011	Agency for Healthcare Research and Quality (AHRQ)	Enabling medication management through health information technology
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Infliximab (Remicade) for paediatric ulcerative colitis
2011	HAYES, Inc.	Computer-aided detection of pulmonary embolism
2011	National Institute for Health and Care Excellence (NICE)	Percutaneous laser coronary angioplasty. NICE interventional procedures guidance 378
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Amniotic Fluid Lactate monitoring system for dysfunctional labour
2011	HAYES, Inc.	Computer-Aided Semen Analysis (CASA) for the diagnosis of male infertility
2011	National Institute for Health and Care Excellence (NICE)	Thoracoscopic repair of congenital diaphragmatic hernia in neonates. NICE interventional procedures guidance 379
2011	HAYES, Inc.	Previstage GCC colorectal cancer staging test
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Placental growth factor based tests for the diagnosis of pre-eclampsia
2011	HAYES, Inc.	Electrocardiogram signal analysis for diagnosis of coronary artery disease: body surface mapping
2011	National Institute for Health and Care Excellence (NICE)	Distal iliotibial band lengthening for refractory greater trochanteric pain syndrome. NICE interventional procedures guidance 375
2011	Agency for Healthcare Research and Quality (AHRQ)	A framework for "best evidence" approaches in systematic reviews
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Everolimus (Afinitor) for advanced gastric cancer - second line
2011	HAYES, Inc.	Electrocardiogram signal-based analysis for diagnosis of coronary artery disease: multifunction cardiogram and signal-averaged electrocardiogram
2011	Agency for Healthcare Research and Quality (AHRQ)	Health literacy interventions and outcomes: an updated systematic review
2011	NIHR Horizon Scanning Centre (NIHR HSC)	GSK1120212 for unresectable or metastatic melanoma, BRAF V600 mutation-positive in adults
2011	HAYES, Inc.	Functional electrical stimulation for rehabilitation following spinal cord injury
2011	NIHR Horizon Scanning Centre (NIHR HSC)	GSK2118436 (dabrafenib) for malignant melanoma: advanced and/or metastatic (stage III or IV), BRAF V600E mutation - first line
2011	HAYES, Inc.	Intensive behavioral intervention therapy for autism
2011	HAYES, Inc.	Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS; Familial Hibernian Fever)
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Regorafenib for metastatic colorectal cancer - third or fourth line
2011	HAYES, Inc.	Local injection therapy and neurosurgery for cervicogenic headache and occipital neuralgia
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Sorafenib (Nexavar) for hepatocellular carcinoma - adjuvant therapy
2011	NIHR Health Technology Assessment programme	Cabazitaxel for the second-line treatment of hormone refractory, metastatic prostate cancer: a single technology appraisal
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Sorafenib (Nexavar) in combination with capecitabine for HER2-negative locally advanced or metastatic breast cancer - second line
2011	HAYES, Inc.	Meniscal allograft transplantation
2011	Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS)	Prostate cancer screening
2011	NIHR Health Technology Assessment programme	Long-acting exenatide in the management of type 2 diabetes
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Exenatide (Byetta) for type 2 diabetes mellitus - in combination with basal insulin
2011	HAYES, Inc.	Minimally invasive coronary artery bypass graft surgeries for coronary revascularization
2011	Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS)	Nasopharyngeal carcinoma screening
2011	Belgian Health Care Knowledge Centre (KCE)	Economic evaluation of antiviral treatment of chronic hepatitis B in Belgium - Part 2
2011	NIHR Health Technology Assessment programme	Ipilimumab for previously treated unresectable malignant melanoma
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Aganirsen for pathological corneal neovascularisation
2011	HAYES, Inc.	Neuronavigation for intracranial biopsy and intracranial surgery
2011	Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS)	HPV DNA-based screening test for cervical cancer
2011	NIHR Health Technology Assessment programme	Apixaban for the prevention of venous thromboembolism in people undergoing elective knee and hip replacement surgery
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Idebenone (Catena) for leber's hereditary optic neuropathy - first line
2011	HAYES, Inc.	Optical coherence tomography for coronary artery plaque characterization and stent evaluation
2011	Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS)	Immunochemical faecal occult blood test (IFOBT) for colorectal cancer screening
2011	Belgian Health Care Knowledge Centre (KCE)	Home oxygen therapy
2011	NIHR Health Technology Assessment programme	Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation: a single technology appraisal
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Ranibizumab (Lucentis) for visual impairment due to choroidal neovascularisation (CNV) secondary to pathological myopia - first line
2011	HAYES, Inc.	Positron Emission Tomography (PET) and Combined Positron Emission Tomography-Computed Tomography (PET-CT) for detection of recurrent ovarian cancer
2011	HAYES, Inc.	Brachytherapy for breast cancer
2011	NIHR Health Technology Assessment programme	Boceprevir for the treatment of genotype 1 chronic hepatitis C
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Defibrotide (Defitelio) for hepatic veno-occlusive disease in haematopoietic stem cell transplantation - first line
2011	HAYES, Inc.	Positron Emission Tomography (PET) and Combined Positron Emission Tomography-Computed Tomography (PET-CT) for diagnosis and management of soft tissue sarcoma
2011	Belgian Health Care Knowledge Centre (KCE)	Cost-effectiveness of 10- and 13-valent pneumococcal conjugate vaccines in childhood
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Certolizumab pegol (Cimzia) for active ankylosing spondylitis (AS) - second or third line; after intolerance or inadequate response to at least one non-steroidal anti-inflammatory drug (NSAID)
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Denosumab (Prolia) for osteoporosis in men
2011	HAYES, Inc.	Selective Estrogen Receptor Modulators (SERMs) for chemoprevention of breast cancer
2011	HAYES, Inc.	Cognitive-behavioral therapy for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in adults
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Laquinimod for multiple sclerosis: relapsing-remitting - first or second line.
2011	HAYES, Inc.	Signal-Averaged Electrocardiogram (SAECG) to identify risk of ventricular tachyarrhythmias and sudden cardiac death
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Teriflunomide for relapsing multiple sclerosis (MS) - first line
2011	HAYES, Inc.	Social skills training for autistic spectrum disorders
2011	HAYES, Inc.	Alport syndrome
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Eculizumab (Soliris) for atypical haemolytic uraemic syndrome - first line
2011	NIHR Health Technology Assessment programme	The clinical effectiveness and cost-effectiveness of exercise referral schemes: a systematic review and economic evaluation
2011	HAYES, Inc.	Full-field digital mammography for breast cancer screening
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Indacaterol/glycopyrronium (QVA-149) for chronic obstructive pulmonary disease
2011	HAYES, Inc.	Sublingual immunotherapy for allergic rhinitis
2011	NIHR Health Technology Assessment programme	Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review
2011	The Regional Health Technology Assessment Centre (HTA-centrum)	Pulse oximetry (POX) screening for congenital heart defects in newborns
2011	HAYES, Inc.	Telerehabilitation after stroke
2011	The Regional Health Technology Assessment Centre (HTA-centrum)	[Treatment in relapsed multiple myeloma; bortezomib, lenalidomide, thalidomide]
2011	HAYES, Inc.	Total ankle replacement
2011	NIHR Health Technology Assessment programme	Hemiarthroplasty and total hip arthroplasty for treating primary intracapsular fracture of the hip: a systematic review and cost-effectiveness analysis
2011	HAYES, Inc.	Lipoprotein-associated phospholipase testing for stroke assessment in adults
2011	HAYES, Inc.	Trofile™ HIV tropism assay
2011	HAYES, Inc.	Vision therapy for accommodative and vergence dysfunction
2011	HAYES, Inc.	Minimally invasive total hip arthroplasty
2011	NIHR Health Technology Assessment programme	A 1-year follow-on study from a randomised, head-to-head, multicentre, open-label study of two pandemic influenza vaccines in children
2011	HAYES, Inc.	Nicotine replacement therapy for smoking cessation: nicotine gum and nicotine lozenge
2011	HAYES, Inc.	Nicotine replacement therapy for smoking cessation: nicotine nasal spray and nicotine inhaler
2011	HAYES, Inc.	Nicotine replacement therapy for smoking cessation: nicotine patch
2011	HAYES, Inc.	NovoSeven coagulation factor VIIa (recombinant) for prevention and control of bleeding in patients without hemophilia
2010	NIHR Health Technology Assessment programme	A randomised 2x2 trial of community versus hospital pulmonary rehabilitation, followed by telephone or conventional follow-up
2010	NIHR Health Technology Assessment programme	Evaluation of droplet dispersion during non-invasive ventilation, oxygen therapy, nebuliser treatment and chest physiotherapy in clinical practice: implications for management of pandemic influenza and other airborne infections.
2010	NIHR Health Technology Assessment programme	Virus shedding and environmental deposition of novel A(H1N1) pandemic influenza virus
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Methods to screen for hemoglobin S in blood donors selected for exchange transfusions: a review of the clinical effectiveness and guidelines
2010	National Institute for Health and Care Excellence (NICE)	Haemorrhoidal artery ligation. NICE interventional procedures guidance 342
2010	NIHR Health Technology Assessment programme	Evaluation of triage methods used to select patients with suspected pandemic influenza for hospital admission: cohort study
2010	HAYES, Inc.	Paclitaxel-eluting stents for treatment of coronary artery disease
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Optimizing the implementation of diagnostic imaging decision support tools: a review of the evidence and guidelines
2010	National Institute for Health and Care Excellence (NICE)	Arteriovenous crossing sheathotomy for branch retinal vein occlusion. NICE interventional procedures guidance 334
2010	NIHR Health Technology Assessment programme	Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03B/oil-in-water emulsion- adjuvanted (AS03B) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of age
2010	HAYES, Inc.	Photodynamic therapy for actinic keratosis and squamous cell carcinoma in situ
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Cannabinoids as co-analgesics: review of clinical effectiveness
2010	National Institute for Health and Care Excellence (NICE)	Endoscopic submucosal dissection of lower gastrointestinal lesions. NICE interventional procedures guidance 335
2010	NIHR Health Technology Assessment programme	Virus shedding and environmental deposition of novel A (H1N1) pandemic influenza virus: interim findings
2010	HAYES, Inc.	Photodynamic therapy for nonmelanoma skin cancer
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Phosphodiesterase 5 inhibitors: a review of the clinical effectiveness and cost-effectiveness
2010	National Institute for Health and Care Excellence (NICE)	Transcatheter endovascular closure of perimembranous ventricular septal defect. NICE interventional procedures guidance 336
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Negative pressure therapy for patients infected wounds: a review of the clinical and cost-effectiveness evidence and recommendations for use
2010	National Institute for Health and Care Excellence (NICE)	Endobronchial ultrasound-guided transbronchial biopsy for peripheral lung lesions. NICE interventional procedures guidance 337